SCHEMBL29238680

SCHEMBL29238680

CC(=O)C1=NNC=CC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5583489 0.81
SCHEMBL3969262 0.79
Hydrochloric Acid SCHEMBL3963502 0.78
Piperazine SCHEMBL7414302 0.73
Pyrrole SCHEMBL18797670 0.71
SCHEMBL8428656 0.71 KMT2A (0.36)
SCHEMBL460674 0.68
SCHEMBL16238310 0.66
SCHEMBL3542282 0.66
SCHEMBL28669823 0.64 EPHX1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118105369-A Eight compounds capable of improving ACE2 activity 北京市糖尿病研究所(北京市糖尿病防治办公室) 2024-05-31 CN disclosed
CN-118021831-A Application of Protodioscin as ACE2 Agonist 北京市糖尿病研究所(北京市糖尿病防治办公室) 2024-05-14 CN disclosed